Nov
DEC
Jan
19
2014
2015
2016
1 captures
19 Dec 15 - 19 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Inflammatory Disorders
Gout Guidelines: The Good, the Bad, and the Future
Guidelines for PMR Favor Lowest Effective Dose of GCs as Initial Therapy
New Approaches to Corticosteroid Resistance
Secukinumab is Effective Treatment for Active PsA
Eosinophilic Lung Diseases: What They Are, How They Differ
Sarcoidosis Epidemiology, Clinical Presentation, Small Fiber Neuropathy, and Options beyond Prednisone
Lesinurad Provides Additional Lowering of SUA in Gout
APR Improves PsA Symptoms Out to Week 104
Efficacy of Secukinumab Sustained over Time for Treatment of Active PsA
FUTURE 1: Secukinumab Inhibits Radiographic Disease Progression in PsA
Pages
Next
1
2